Sublative Skin Rejuvenation

elos Plus_Logo

Safely Restore Youthful, Healthy Looking Skin

Safely and comfortably fade the appearance of skin imperfections caused by the sun, and uneven skin tones caused by brown and red spots (such as rosacea, spider veins and age spots).

We’re proud to offer elōs, the first and only technology that uses combined energies to effectively and gently restore and rejuvenate the appearance of your skin.

Skin Rejuvenation

How does skin rejuvenation with elōs work?

The combined bi-polar radio frequency and light energies of elōs technology prcisely and safely target pigmented lesions such as freckles, sun spots and age spots. Vascular lesions such as spider vessels and redness from rosacea are also lightened and gradually fade.


Is skin rejuvenation with elōs right for me?

elōs is an effective treatment for most skin types.


When can I expect to see results?

Gradual and cumulative improvement of skin tone is typically achieved in 5 treatment sessions. The total number of required treatment sessions depends on your skin’s condition. Schedule a consultation to establish your personalized treatment schedule.


Does it hurt?

Cooling off the skin surface ensures additional safety during treatment. This is a no-downtime procedure. Most patients return to normal activity immediately after treatment.


Goals of Vascular and Pigmented Lesion Treatment

Skin rejuvenation is a term referring to a variety of skin treatments simultaneously addressing different types of lesions.

The SRA applicator is intended for the treatment of superficial benign pigmented and vascular lesions, (such as telangiectasia, rosacea, poikiloderma and angioma), thus leading to improved skin appearance.

The SRA applicator is recommended for the treatment of lesions that are more resistant and difficult to treat, such as light color pigmented lesions and fine caliber telangiectasia. It is also recommended for treatment once the lesion has been lightened, usually after 2-3 treatments with the SR applicator.

The SRA procedure provides a complete area treatment for body areas such as the face, neck, chest, hands and arms. It can be also be employed on sporadic lesions anywhere on the body.

The SRA application utilizes the elōs technology which combines pulsed light optical energy in the visible and the near infrared range, and radio-frequency (RF) energy. Both optical and RF components are delivered to the skin as a combined pulse resulting in an efficient and safe treatment.

The optical energy targets the different chromophores. The SRA applicator emits light at a wavelength of 470-980 nm, and superficial melanin and hemoglobin absorb well in this wavelength range. Thus target lesions such as lentigines and telangiectasias absorb the optical energy that is converted to heat, raising the temperature of the target tissue.

Because the temperature is inversely proportional to the impedance, as temperature increases the impedance of the target lesion decreases and thus attracts the RF current.

Additionally, RF energy flows to the heated area and further elevates the temperature of the target lesions to a level required for destruction. RF energy is not selectively absorbed by chromophores and is thus independent of skin color.

Since the epidermis is constantly cooled it is protected from collateral damage. RF energy heats the dermal zone, contributing to overall improvements in the skin’s appearance.

The system continually monitors skin temperature, which is inversely proportional to the measured impedance drop, reducing the possible incidence of side effects by preventing tissue overheating.


Realistic Expectations

SRA treatment may improve the appearance of photo-aged skin by clearing the superficial pigmented and vascular lesions.

The degree of improvement and the number of sessions required vary in patients with different lesion types and severity. It may also appear that some stubborn lesions will show less clearance than others on the same treatment area.

Superficial pigmented lesions such as freckles, sun spots, age spots, sun damage and hyperpigmentation tend to respond well to treatment with the SR applicator. However, when the lesions lighten, higher fluence may be required to clear them.

Some resistant pigmented lesions may need a more aggressive treatment using the SRA applicator. Superficial melasma presents a special concern, as it is a condition controlled by hormones and may reoccur. Furthermore, the response is unpredictable; some patients may show no response or even darkening of the lesion.

Vascular lesions are more difficult to treat because of the range of vessel sizes and depths. Higher optical values are needed for vascular than for pigmented lesions. Fine caliber vessels are better treated with the SRA applicator.

Aged skin with pigmented and structural damage in the form of wrinkles may show a better general improvement when combining the SRA treatment with the Sublime procedure. The Sublime passes may be performed immediately following the SRA treatment.

Treatment of male patients in hair-bearing areas may result in some damage to the follicles and subsequent loss of hair. Avoid the beard area and other hair growing zones if the patient does not wish to have reduction of the hair growth.



The SRA Applicator is indicated for superficial benign vascular and pigmented lesion treatment.



These conditions may prevent you from using the treatment:

  • Pacemaker or internal defibrillator.
  • Superficial metal or other implants in the treatment area.
  • Current or history of skin cancer, or current condition of any other type of cancer, or pre-malignant moles.
  • History of any kind of cancer.
  • Severe concurrent conditions, such as cardiac disorders.
  • Pregnancy and nursing.
  • Impaired immune system due to immunosuppressive diseases such as AIDS and HIV, or use of immunosuppressive medications.
  • Diseases which may be stimulated by light at the wavelengths used, such as history of Systemic Lupus Erythematosus, Porphyria, and Epilepsy.
  • Patients with history of diseases stimulated by heat, such as recurrent Herpes Simplex in the treatment area, may be treated only following a prophylactic regimen.
  • Poorly controlled endocrine disorders, such as Diabetes.
  • Any active condition in the treatment area, such as sores, Psoriasis, eczema, and rash.
  • History of skin disorders, keloids, abnormal wound healing, as well as very dry and fragile skin.
  • History of bleeding coagulopathies, or use of anticoagulants with the exception of preventive low dose aspirin medication.
  • Use of medications, herbs, food supplements, and vitamins known to induce photosensitivity to light exposure at the wavelengths used, such as Isotretinoin (Accutane) within the last six months, Tetracyclines, or St. John’s Wort within the last two weeks.
  • Facial laser resurfacing and deep chemical peeling within the last three months, if face is treated.
  • Any surgical procedure in the treatment area within the last three months or before complete healing.
  • Treating over tattoo or permanent makeup.
  • Tanned skin from sun, tanning beds or tanning creams within the last two weeks.
  • As per the practitioner’s discretion, refrain from treating any condition which might make it unsafe for the patient.


Possible Side Effects

Although these effects are rare and expected to be transient, any adverse reaction should be immediately reported to the physician.

Side effects may include any of those conditions listed below.

Side effects may appear either at the time of treatment or shortly after. Dark-skinned patients may have a delayed response one-to-two days after treatment and should be evaluated post-test spot accordingly.

The side effects may include:

  • Pain
  • Skin redness (erythema).
  • Excessive swelling (edema).
  • Damage to natural skin texture (crust, blister, burn).
  • Change of pigmentation (hyper- and hypo-pigmentation).
  • Scarring
  • Bruising


Pre-Treatment Preparation

Before treatments begin, your doctor will do the following:

  • Complete or update medical and physical history.
  • Exclude from treatment patients with contraindications for treatment.
  • Determine why the patient is seeking treatment and what his/her expectations are.
  • Inform the patient about the treatment protocol, typical treatment results and possible adverse effects and discomfort.
  • Instruct the patient about the safety issues.
  • Advise the patient to avoid skin irritation or intentional skin tanning. Sunscreen is advisable when outdoors during daylight hours.
  • The patient should discontinue any irritant topical agents for 2-3 days prior to treatment.
  • The patient should arrive for treatment with clean skin. There should be no lotion, make-up, perfume, deodorant, powder or bath/shower oil present on the skin in the area to be treated. Before treatment, wipe the treatment area with a non-alcoholic preparation.
  • The patient should be placed in a supine or semi-recumbent position to allow access to the treatment location.
  • A topical anesthetic should be used only if necessary and according to the physician’s discretion.
  • Areas of dental crowns, caps, braces, or other metal dental implants may be more sensitive to treatment and the clinician may use dental rolls, gauze or a tongue depressor to isolate the area and make the treatment more comfortable.
  • Before each treatment clean the entire applicator surface with a medical disinfectant. Wipe the applicator tip with alcohol. Let the tip dry completely before pulsing. Cleaning of the applicator should always be done while system is set to Standby mode or turned off.
  • Caution
  • The area to be treated should be shaved. Unshaved hair absorbs optical energy, preventing energy delivery to the tissue and interrupting with electrode coupling to the skin.
  • When treating highly contoured body areas, position the applicator to assure maximum contact with the skin surface and select Sensitive mode.
  • In hot seasons, blood vessels tend to be dilated and pigmentation may be enhanced by sun exposure or elevated temperatures. Extra caution should be exercised (e.g. test spots). It is sometimes recommended for the patient to rest in a cool place before treatment.


Treatment Protocol

  • Typically 2-4 sessions, 3-4 weeks apart are sufficient, especially if performed after 2-3 sessions with SR.
  • With severe photodamage of dark diffuse pigmentation, it is recommended to lighten the lesions using the SR applicator for 2-3 sessions before the SRA applicator is used, or to use the SRA with lower optical parameters.
  • Touch-up of 1 session may be needed every 4-8 months.


Post-Treatment Care

  • In the event of post-treatment discomfort, it is recommended to cool the treated area immediately following treatment with cold (not frozen) packs, air cooling with SynerCool, etc.
  • Blistered or ulcerated skin can be treated with a prescribed antibiotic ointment or burn treatment cream.
  • During the first two days following treatment, care should be taken to prevent trauma to the treated site: avoid hot baths, massage, etc.
  • If scabs appear, they should be kept soft with a lubricating ointment.
  • The patient should use high factor sunscreen (> SPF 30) and protect the treated area from sunlight for at least one month after the treatment. Tanning after treatment may cause hyperpigmentation.



The following are recommendations for post-treatment follow-up.

The most suitable regimen for each patient will be determined on an individual basis.

  • The patient should return 3-4 weeks following treatment for treatment site evaluation.
  • Update the patient’s medical history while being mindful of sun tanning, new medications, etc. If the patient presents no contraindications perform another treatment.
  • Prior to the treatment, perform a test spot in order to choose the adequate treatment parameters as follows:  If partial clearance is observed and no adverse events occurred, treatment should be continued using the same or 10% higher parameters.  If no results are observed, the treatment parameters should be increased.
  • As the lesions become lighter during the course of treatment, it may be necessary to increase the treatment parameters.  If the patient has experienced adverse events along with clearance, the treatment parameters should be decreased.
  • If no clearance was observed and adverse effects were noticed, treatment should be discontinued.